Cancer With Transdermal Accessible Tumour
1 clinical trials · Condition
◉ Watch Cancer With Transdermal Accessible Tumour
| Record | Firm | Date |
|---|---|---|
| Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour (NCT01058616) | Lytix Biopharma AS | 2010-01-01 |
Track Cancer With Transdermal Accessible Tumour automatically
Every clearance here is in the API, with alerts when new ones post.